ArticleCureus2025
Physical Growth Dynamics of Children With Juvenile Dermatomyositis.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Impact of Juvenile Dermatomyositis on Growth, Puberty, Bone Mineral Density, and Body Composition in Children.Mediterranean journal of rheumatology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective Growth failure is an often overlooked complication of juvenile dermatomyositis (JDMS) hence, the present study analyses the auxological status of adolescent JDMS patients. Methods Sixty serial observations with respect to height, weight, and skinfold thicknesses were made on 35 JDMS children aged 10 to 17 years in the Growth Laboratory/Clinic of the Department following a mixed-longitudinal growth research design. Information with regard to disease duration and disease activity (MMT-8 score) was recorded. Results The mean height and weight of JDMS patients showed a regular increase from 10 to 17 years while BMI depicted an undulating pattern. JDMS boys were taller yet weighed lighter and had lesser sub-cutaneous fat deposition than girls. As compared to their normal counterparts, JDMS children were lighter and shorter, however, JDMS girls caught up and became heavier and taller beyond 12 and 14 years, respectively. Only 4 (6.6%) and 5 (8.33%) of our study subjects were short-statured and underweight, respectively. Disease activity had a significant positive correlation with the physical growth of JDMS boys. Conclusion JDMS boys depicted compromised growth when contrasted with their unaffected counterparts; this may be due to the influence of disease activity on their physical growth. However, better auxological prognosis recorded for JDMS girls beyond 12-13 years reveals that there must be some protective mechanism favoring girls making them resistant to adverse effects of the disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.